Home > PS Ratio > SHILPA MEDICARE

SHILPA MEDICARE
PS (Price/Sales) Ratio

The Current P/S Ratio of SHILPA MEDICARE is 6.16.

Share Price ₹764.8Dec 26,2024
Market Cap ₹7,479.3 Cr
Sales-TTM₹1,214.5 CrTTM-Consolidated Results
Price/Sales6.16xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SHILPA MEDICARE
Please provide your vote to see the results
SHILPA MEDICARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SHILPA MEDICARE

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SHILPA MEDICARE is calculated as :

Current Market Cap [ ₹7,479.3 Cr] as on Dec 26,2024

(/) Sales [ ₹1,214.5 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 6.16x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SHILPA MEDICARE , the investors are currently willing to pay '6.16 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SHILPA MEDICARE !

The chart below summarizes the trend in P/S Ratio of SHILPA MEDICARE over the last five years.

Historical PS (Price/Sales) ratio chart of SHILPA MEDICARE


PS Ratio Performance Analysis for SHILPA MEDICARE

- SHILPA MEDICARE 's latest p/e ratio is 6.16x.

- SHILPA MEDICARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.72x.

- SHILPA MEDICARE 's operated at median p/e ratio of 3.01x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SHILPA MEDICARE 's p/e ratio peaked in Mar2024 at 3.48x.

- SHILPA MEDICARE 's p/e ratio hit its five-year low in Mar2023 of 1.9x.


How does SHILPA MEDICARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SHILPA MEDICARE 1,214.56.167,479.3
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.78441,838.0
CIPLA LTD26,512.04.54120,270.0
DR REDDYS LABORATORIES LTD30,084.93.76113,077.0
ZYDUS LIFESCIENCES LTD21,483.54.4996,553.2
DIVIS LABORATORIES LTD8,614.018.12156,107.0
MANKIND PHARMA LTD11,018.010.91120,212.0
TORRENT PHARMACEUTICALS LTD11,225.010.30115,643.0
LUPIN LTD21,431.34.6499,532.1
AUROBINDO PHARMA LTD30,295.02.4172,945.8
ABBOTT INDIA LTD6,066.110.0360,844.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHILPA MEDICARE 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.41x
Max industry PS 18.12x
Median industry PS 6.16x
Average industry PS 7.65x



You may also like the below Video Courses